PALO ALTO, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (VINC) (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through ...

Oracle Argus Safety processes 10 million adverse event cases annually for pharmaceutical companies worldwide, according to Oracle. Yet module-specific issues continue to delay regulatory submissions, ...

The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. The data come from 20 pharmas that had the highest R&D budgets in 2020, as ...

Royalty Pharma plc announced that its shareholders overwhelmingly approved the acquisition of its external manager, achieving 99.9% support during the 2025 Annual General Meeting. This transition to ...